ArticleJournal for immunotherapy of cancer2023

Dual inhibition of BTLA and PD-1 can enhance therapeutic efficacy of paclitaxel on intraperitoneally disseminated tumors.

Wei-Zen Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.